Second booster of BNT162b2 or full-dose mRNA-1273 in adults ≥ 75 years

被引：0
|
作者：
Marin-Hernandez, Daniela
机构：
来源：
LANCET REGIONAL HEALTH-EUROPE | 2024年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273
    Steensels, Deborah
    Pierlet, Noella
    Penders, Joris
    Mesotten, Dieter
    Heylen, Line
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1533 - 1535
  • [32] Comparative Effectiveness of BNT162b2 and mRNA-1273 Booster Dose After BNT162b2 Primary Vaccination Against the Omicron Variants: A Retrospective Cohort Study Using Large-Scale Population-Based Registries in Japan
    Ono, Sachiko
    Michihata, Nobuaki
    Yamana, Hayato
    Uemura, Kohei
    Ono, Yosuke
    Jo, Taisuke
    Yasunaga, Hideo
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (01) : 18 - 24
  • [33] Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection
    Niesen, Michiel J. M.
    Matson, Robert
    Puranik, Arjun
    O'Horo, John C.
    Pawlowski, Colin
    Vachon, Celine
    Challener, Douglas
    Virk, Abinash
    Swift, Melanie
    Speicher, Leigh
    Gordon, Joel
    Geyer, Holly
    Lenehan, Patrick J.
    Venkatakrishnan, A. J.
    Soundararajan, Venky
    Badley, Andrew
    PNAS NEXUS, 2022, 1 (02):
  • [34] Comparative safety of BNT162b2 and mRNA-1273 vaccines across frailty subgroups among 6.4 million older adults
    Harris, D.
    Zullo, A. R.
    Mor, V.
    Hayes, K. N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S127 - S128
  • [35] Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study
    Andersson, Niklas Worm
    Thiesson, Emilia Myrup
    Laursen, Mona Vestergaard
    Mogensen, Stine Hasling
    Kjaer, Jesper
    Hviid, Anders
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 378
  • [36] Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients
    Haller, Maria C.
    Kaiser, Robert A.
    Langthaler, Simon
    Brandstetter, Clara
    Apfalter, Petra
    Kerschner, Heidrun
    Cejka, Daniel
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [37] Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors
    Ballman, Madison
    Swift, Shannon
    Mullenix, Cristina
    Mallory, Yvonne
    Zhao, Chen
    Szabo, Eva
    Shelat, Meenakshi
    Sansone, Susan
    Steinberg, Seth M.
    Mcadams, Meredith J.
    Rajan, Arun
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (10):
  • [38] Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies
    Kohmer, Niko
    Rabenau, Holger F.
    Ciesek, Sandra
    Kraemer, Bernhard K.
    Goettmann, Uwe
    Keller, Christine
    Rose, Daniela
    Blume, Carsten
    Thomas, Michael
    Lammert, Alexander
    Lammert, Anne
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (06) : 1132 - 1139
  • [39] Myocarditis after BNT162b2 and mRNA-1273 COVID-19 vaccination: A report of 7 cases
    Ahmed, Sirwan Khalid
    ANNALS OF MEDICINE AND SURGERY, 2022, 77
  • [40] Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study
    Romero-Brufau, Santiago
    Chopra, Ayush
    Ryu, Alex J.
    Gel, Esma
    Raskar, Ramesh
    Kremers, Walter
    Anderson, Karen S.
    Subramanian, Jayakumar
    Krishnamurthy, Balaji
    Singh, Abhishek
    Pasupathy, Kalyan
    Dong, Yue
    O'Horo, John C.
    Wilson, Walter R.
    Mitchell, Oscar
    Kingsley, Thomas C.
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
12345